Device Therapies Beyond Renal Denervation

Lecture collection · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Device decisions also depend on procedural safety, durability, patient selection, downstream clinical outcomes, and the current authorization for the specific device and indication.

Device Therapies Beyond Renal Denervation: six-panel learning summary. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

Recheck resistant hypertension

Confirm genuine resistant hypertension and address measurement, medicines, access, and secondary causes before discussing an invasive device.

Understand baroreflex activation

Baroreflex activation modifies autonomic signaling, but evidence is device-, procedure-, and population-specific.

Read the whole trial

Review all prespecified endpoints and procedural harms; partial trial success and a small pilot do not establish universal benefit.

Consider vascular approaches

Evaluate vascular-mechanical approaches by pressure effects, invasive complications, venous and cardiac consequences, and long-term outcomes.

Keep the research context clear

Check the actual evidence and current status of each approach; a mechanism or trial title does not establish routine availability or endorsement.

Discuss choices honestly

Discuss uncertainty, alternatives, procedural burden, and ongoing monitoring with the patient and specialist team.

Continue learning

This graphic summarizes a topic. The full educational pages provide the broader discussion and references.